PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-52.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-84.03%
Negative gross profit growth while 6247.T is at 1.84%. Joel Greenblatt would examine cost competitiveness or demand decline.
-153.45%
Negative EBIT growth while 6247.T is at 863.62%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-154.62%
Negative operating income growth while 6247.T is at 9.42%. Joel Greenblatt would press for urgent turnaround measures.
-190.27%
Negative net income growth while 6247.T stands at 786.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-190.28%
Negative EPS growth while 6247.T is at 787.03%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-190.28%
Negative diluted EPS growth while 6247.T is at 787.03%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-77.63%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-77.63%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-77.63%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
79.18%
Net income/share CAGR at 75-90% of 6247.T's 103.00%. Bill Ackman would press for strategic moves to boost long-term earnings.
79.18%
5Y net income/share CAGR at 75-90% of 6247.T's 103.00%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
79.18%
3Y net income/share CAGR 75-90% of 6247.T's 103.00%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
53.04%
Inventory growth well above 6247.T's 19.25%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
12.28%
Asset growth above 1.5x 6247.T's 2.49%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-21.85%
We have a declining book value while 6247.T shows 1.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.76%
We have some new debt while 6247.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.